CDTX vs EW · rev $1.3M vs P/E 47, rev $1.39B
Cidara Therapeutics Inc (CDTX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CDTX currently screens at market cap $6.96B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CDTX and EW stock pages for the full models.
Not investment advice.